BPC-157 + TB500 Wolverine

About the substance

Wolverine combines two peptides in one pen: 10 mg BPC-157 and 10 mg TB500, giving 20 mg of active peptides in a 50/50 blend. The TB500 component is synthetic thymosin beta-4, composed of 43 amino acids.

How it works

The components are discussed in experimental tissue-repair biology through different mechanisms. BPC-157 has been investigated in relation to cell attachment and movement, while thymosin beta-4 interacts with actin, a protein involved in cell structure and migration. These mechanisms help explain interest in the combination, but do not prove a clinical benefit for the blend.

What studies have examined

The linked publications provide background on individual substances and experimental models. Neither is a clinical trial of this Wolverine pen. Combining ingredients does not turn separate observations into evidence for the finished blend.

How to interpret the findings

Claims of synergy require an actual comparison of the combination with its individual components. A blend name, two ingredient names or a larger total quantity cannot demonstrate synergy, faster healing or better results. Stability and compatibility of a mixed preparation also require product-specific documentation.

Product specifications

• Format: Ready-mixed peptide pen
• Stated total quantity: 20 mg

The pen contains 20 mg total in a 50/50 blend: 10 mg BPC-157 and 10 mg TB500. These quantities refer to the full contents of the pen, not an individual dose.

Documentation and handling

For details about identity, content and the available certificate, contact info@nordicpept.com and specify the product and batch. Follow the storage and handling instructions supplied with the actual product. A publication about an ingredient is not a certificate for a finished pen.

Selected studies

• BPC-157: Chang et al., 2011
• Thymosin beta-4: Malinda et al., 1999